NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/07/2026
Back to search
Official data from USPTO
CLINICAL RESEARCH OPTIMIZED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL RESEARCH OPTIMIZED
ST13
US500000087945098Class
35
Filing
87945098
Registration
5666187
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
01/08/2026
Trademark type
Word
Nice classes
35
Filing date
06/01/2018
Registration date
01/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2026
Last transaction
01/08/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
10/01/2014
First use in commerce
10/01/2014
Drawing code
4
Owner type
16
Owner location
Aventura, FL
Examiner
JOHNSON, DONALD
Current location
Historical data usage
Holders and representatives
Holders
BIORASI, LLC
Representatives
BIORASI, LLC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consultation in the field of clinical trials and developmentbiosimilar trialsclinical servicesprogram developmentregulatory guidance and compliancesafety and pharmacovigilancedata science and biometrics; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting and management in the field of clinical trialsproviding information management services; Business management and consultation in the field of clinical trials and developmentbiosimilar trialsclinical servicesprogram developmentregulatory guidance and compliancesafety and pharmacovigilancedata science and biometrics; Business project management services; Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
Publications
History of USPTO decisions and trademark events.
20 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/29/2024
ES8R
TEAS SECTION 8 RECEIVED
01/29/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/29/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/11/2018
ALIE
ASSIGNED TO LIE
10/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/21/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/21/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/21/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/21/2018
DOCK
ASSIGNED TO EXAMINER
09/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2018
NWAP
NEW APPLICATION ENTERED
06/05/2018
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL RESEARCH OPTIMIZED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.